Crossmark

A novel Autologous Cytokine-Rich Serum (SARC) to treat knee osteoarthritis patients’ refractory to a previous glucocorticoid intra-articular injection. A pilot study

Crossref DOI link: https://doi.org/10.1016/j.reumae.2025.502016

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Orellana, Cristóbal

Garcia Cirera, Silvia

Rodrigo Parés, Albert

Uriel Brotons, Laia

Arqué Corredor, Àlex

Aymerich, Cristina

Gómez, Rafael

Carreras, Anna

Berenguer-Llergo, Antoni

Calvet, Joan
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01
More Information

This article is maintained by: Elsevier

Article Title: A novel Autologous Cytokine-Rich Serum (SARC) to treat knee osteoarthritis patients’ refractory to a previous glucocorticoid intra-articular injection. A pilot study

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2025.502016

Content Type: article

Copyright: © 2025 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below